$1.26 a share now with all that's known about Neuralstem -
imho, CUR should be $12.60 a share now - with what they have accomplished thus far.
What is it that "The Street" wants? - ALS & SCI patients doing head-stands & backflips following their initial stem cell surgeries? JEEEEEEEEEEESSSSSSSSSSHHHHHHH!!!!!
The "STREET" wants blood and positioning before they allow a decent stock to rise in price ..
There is no such thing as normal investing in the stock market . .
"PLAYING" is the name that has been associated with the market and they know how to play it well ,having plenty of money and various connections to call fleecing the unaware , unsuspecting investor of what they consider a percentage of their money .
They can see more information to make their decisions than any small investor can .
It is almost like playing poker with some one who has their cards laid out face up on the table while the maniper's are holding them close to their chests . ..
A well known and repeated phrase fits into the puzzle perfectly
"LIKE TAKING CANDY FROM A BABY"
Still leaves CUR as a very good investment if you are willing to understand the time factor ..
I get your drift, 'stahlz" - but I still maintain that if Mr. Garr & company ink a partnership deal with "big pharma or big biotech' to cover both #566 & #189 - it will be a seminal moment in this companys future.